Literature DB >> 26169829

Impact of the N-Terminal Domain of STAT3 in STAT3-Dependent Transcriptional Activity.

Tiancen Hu1, Jennifer E Yeh2, Luca Pinello3, Jaison Jacob4, Srinivas Chakravarthy5, Guo-Cheng Yuan3, Rajiv Chopra6, David A Frank7.   

Abstract

The transcription factor STAT3 is constitutively active in many cancers, where it mediates important biological effects, including cell proliferation, differentiation, survival, and angiogenesis. The N-terminal domain (NTD) of STAT3 performs multiple functions, such as cooperative DNA binding, nuclear translocation, and protein-protein interactions. However, it is unclear which subsets of STAT3 target genes depend on the NTD for transcriptional regulation. To identify such genes, we compared gene expression in STAT3-null mouse embryonic fibroblasts (MEFs) stably expressing wild-type STAT3 or STAT3 from which NTD was deleted. NTD deletion reduced the cytokine-induced expression of specific STAT3 target genes by decreasing STAT3 binding to their regulatory regions. To better understand the potential mechanisms of this effect, we determined the crystal structure of the STAT3 NTD and identified a dimer interface responsible for cooperative DNA binding in vitro. We also observed an Ni(2+)-mediated oligomer with an as yet unknown biological function. Mutations on both dimer and Ni(2+)-mediated interfaces affected the cytokine induction of STAT3 target genes. These studies shed light on the role of the NTD in transcriptional regulation by STAT3 and provide a structural template with which to design STAT3 NTD inhibitors with potential therapeutic value.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26169829      PMCID: PMC4561728          DOI: 10.1128/MCB.00060-15

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  76 in total

1.  JASPAR: an open-access database for eukaryotic transcription factor binding profiles.

Authors:  Albin Sandelin; Wynand Alkema; Pär Engström; Wyeth W Wasserman; Boris Lenhard
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

2.  Functional importance of Stat3 tetramerization in activation of the alpha 2-macroglobulin gene.

Authors:  X Zhang; J E Darnell
Journal:  J Biol Chem       Date:  2001-07-03       Impact factor: 5.157

3.  Interaction of STAT5 dimers on two low affinity binding sites mediates interleukin 2 (IL-2) stimulation of IL-2 receptor alpha gene transcription.

Authors:  W K Meyer; P Reichenbach; U Schindler; E Soldaini; M Nabholz
Journal:  J Biol Chem       Date:  1997-12-12       Impact factor: 5.157

4.  The significance of tetramerization in promoter recruitment by Stat5.

Authors:  S John; U Vinkemeier; E Soldaini; J E Darnell; W J Leonard
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

5.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

6.  Novel STAT3 target genes exert distinct roles in the inhibition of mesoderm and endoderm differentiation in cooperation with Nanog.

Authors:  Pierre-Yves Bourillot; Irène Aksoy; Valerie Schreiber; Florence Wianny; Herbert Schulz; Oliver Hummel; Norbert Hubner; Pierre Savatier
Journal:  Stem Cells       Date:  2009-08       Impact factor: 6.277

7.  Mutational switch of an IL-6 response to an interferon-gamma-like response.

Authors:  Ana P Costa-Pereira; Silvia Tininini; Birgit Strobl; Tonino Alonzi; Joerg F Schlaak; Hayaatun Is'harc; Ida Gesualdo; Sally J Newman; Ian M Kerr; Valeria Poli
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

Review 8.  Alternative ways of modulating JAK-STAT pathway: Looking beyond phosphorylation.

Authors:  Olga A Timofeeva; Nadya I Tarasova
Journal:  JAKSTAT       Date:  2012-10-01

9.  Requirement of histone deacetylase1 (HDAC1) in signal transducer and activator of transcription 3 (STAT3) nucleocytoplasmic distribution.

Authors:  Sutapa Ray; Chang Lee; Tieying Hou; Istvan Boldogh; Allan R Brasier
Journal:  Nucleic Acids Res       Date:  2008-07-08       Impact factor: 16.971

10.  Dietary iron enhances colonic inflammation and IL-6/IL-11-Stat3 signaling promoting colonic tumor development in mice.

Authors:  Anita C G Chua; Borut R S Klopcic; Desiree S Ho; S Kristine Fu; Cynthia H Forrest; Kevin D Croft; John K Olynyk; Ian C Lawrance; Debbie Trinder
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

View more
  16 in total

Review 1.  Targeting key transcriptional factor STAT3 in colorectal cancer.

Authors:  Gayathri Chalikonda; Hoomin Lee; Aliya Sheik; Yun Suk Huh
Journal:  Mol Cell Biochem       Date:  2021-04-18       Impact factor: 3.396

Review 2.  The molecular details of cytokine signaling via the JAK/STAT pathway.

Authors:  Rhiannon Morris; Nadia J Kershaw; Jeffrey J Babon
Journal:  Protein Sci       Date:  2018-12       Impact factor: 6.725

3.  Suppression of STAT3 NH2 -terminal domain chemosensitizes medulloblastoma cells by activation of protein inhibitor of activated STAT3 via de-repression by microRNA-21.

Authors:  Sutapa Ray; Don W Coulter; Shawn D Gray; Jason A Sughroue; Shrabasti Roychoudhury; Erin M McIntyre; Nagendra K Chaturvedi; Kishor K Bhakat; Shantaram S Joshi; Timothy R McGuire; John G Sharp
Journal:  Mol Carcinog       Date:  2018-01-25       Impact factor: 4.784

4.  Selective inhibition of STAT3 signaling using monobodies targeting the coiled-coil and N-terminal domains.

Authors:  Grégory La Sala; Camille Michiels; Tim Kükenshöner; Tania Brandstoetter; Barbara Maurer; Akiko Koide; Kelvin Lau; Florence Pojer; Shohei Koide; Veronika Sexl; Laure Dumoutier; Oliver Hantschel
Journal:  Nat Commun       Date:  2020-08-17       Impact factor: 14.919

5.  Therapeutic Ablation of Gain-of-Function Mutant p53 in Colorectal Cancer Inhibits Stat3-Mediated Tumor Growth and Invasion.

Authors:  Ramona Schulz-Heddergott; Nadine Stark; Shelley J Edmunds; Jinyu Li; Lena-Christin Conradi; Hanibal Bohnenberger; Fatih Ceteci; Florian R Greten; Matthias Dobbelstein; Ute M Moll
Journal:  Cancer Cell       Date:  2018-08-13       Impact factor: 31.743

Review 6.  Protective Roles of Apigenin Against Cardiometabolic Diseases: A Systematic Review.

Authors:  Yajie Xu; Xue Li; Hui Wang
Journal:  Front Nutr       Date:  2022-04-15

7.  STAT3 Undergoes Acetylation-dependent Mitochondrial Translocation to Regulate Pyruvate Metabolism.

Authors:  Yan S Xu; Jinyuan J Liang; Yumei Wang; Xiang-Zhong J Zhao; Li Xu; Ye-Yang Xu; Quanli C Zou; Junxun M Zhang; Cheng-E Tu; Yan-Ge Cui; Wei-Hong Sun; Chao Huang; Jing-Hua Yang; Y Eugene Chin
Journal:  Sci Rep       Date:  2016-12-22       Impact factor: 4.379

Review 8.  Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development.

Authors:  Jacopo Sgrignani; Maura Garofalo; Milos Matkovic; Jessica Merulla; Carlo V Catapano; Andrea Cavalli
Journal:  Int J Mol Sci       Date:  2018-05-28       Impact factor: 5.923

9.  MMPP Attenuates Non-Small Cell Lung Cancer Growth by Inhibiting the STAT3 DNA-Binding Activity via Direct Binding to the STAT3 DNA-Binding Domain.

Authors:  Dong Ju Son; Jie Zheng; Yu Yeon Jung; Chul Ju Hwang; Hee Pom Lee; Ju Rang Woo; Song Yi Baek; Young Wan Ham; Min Woong Kang; Minho Shong; Gi Ryang Kweon; Min Jong Song; Jae Kyung Jung; Sang-Bae Han; Bo Yeon Kim; Do Young Yoon; Bu Young Choi; Jin Tae Hong
Journal:  Theranostics       Date:  2017-10-16       Impact factor: 11.556

10.  The commercially available STAT3 inhibitor 5,15-diphenylporphyrin (5,15-DPP) does not directly interact with STAT3 core residues 127-722.

Authors:  Siphokazi Sinethemba Mtwebana; Earl Prinsloo
Journal:  BMC Res Notes       Date:  2020-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.